CorMedix (CRMD) vs Electra Therapeutics (ETRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Electra Therapeutics is the larger company by market cap ($573.7 million vs $570.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRMD | ETRA |
|---|---|---|
| Share price | $7.32 | $9.14 |
| Market cap | $570.55M | $573.69M |
| 1-day change | +0.55% | -0.22% |
| YTD return | -37.06% | — |
| 1-year return | -35.05% | — |
| 5-year return | +47.88% | — |
| P/E ratio (TTM) | 3.57 | — |
| Forward P/E | 20.91 | — |
| EPS (TTM) | $2.05 | $-2.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.02 | $15.50 |
| 52-week low | $6.13 | $8.63 |
| Distance from 52-week high | -43.78% | -41.03% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +109.43% | — |
| Average volume | 1.06M | 912.83K |
| Shares outstanding | 77.94M | 62.77M |
| Employees | 191 | 46 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CorMedix
CRMD stock →CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure.
Health Care · Biotechnology: Pharmaceutical Preparations · 191 employees
About Electra Therapeutics
ETRA stock →Electra Therapeutics, Inc. is a clinical-stage biotechnology company.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 46 employees
CRMD vs ETRA FAQ
Which is bigger, CorMedix or Electra Therapeutics?
Electra Therapeutics (ETRA) is larger, with a market capitalization of $573.69M compared with $570.55M for CorMedix (CRMD).
Are CorMedix and Electra Therapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for CorMedix and Biotechnology: Biological Products (No Diagnostic Substances) for Electra Therapeutics.